8-KItem 5.02 · Officer/Director ChangeItem 8.01 · Other EventsItem 9.01 · Financial Statements
Boston Scientific names Joe Fitzgerald COO and reshapes operating structure
Filed with the SEC on · Summarized by InvestorsBot
Boston Scientific appointed Joseph M. Fitzgerald executive vice president and chief operating officer effective January 1, 2027, with responsibility for global operations, business units and regions. The company will also create three reportable segments—Interventional Therapies, Rhythm Solutions and MedSurg—and appoint Mark Bickel as chief accounting officer effective March 1, 2027, replacing Emily Woodworth, who will move to a finance transformation role.